Back to companies

CSPC Pharmaceutical Group Ltd: Premium Databases

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

CSPC Pharmaceutical Group Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

A sample of CSPC Pharmaceutical Group Insights data

Headline Published Journalists
Showing 3 of 3 results.
Deserunt mollit sunt Lorem laborum do id aliqua dolore 03 Dec 2013 Lorem
Genovate to enter Phase II trial with diabetes drug in Taiwan and China during 3Q14 - source 03 Dec 2013 Ying Huang
Guangzhou Boji Pharma seeks global CRO partners, IPO expected next year – exec 04 Nov 2013 Ying Huang
Proswell Medical in talks with Novartis and Merck for post-marketing oncology studies in China - source 16 May 2013 Ying Huang
Insights

Feature

Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.

Benefit

Drug Insights:

  • Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
  • Material intelligence on competitors, including breaking news
  • Insight on companies’ business development needs and strategies

Outsourcing Insights:

Insight on companies’ CRO and business development needs, strategies and relationships

Value

Remove risk and uncertainty

Gain a competitive edge

Secure actionable leads

Premium databases is part of our industry range of products

Gain a 360-degree view of CSPC Pharmaceutical Group Ltd and make more informed decisions for your business
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer